Wheeler Bio has partnered with Pharmefex Consulting to strengthen its ModularCMC platform by integrating regulatory and CMC expertise for accelerated IND submissions.
Wheeler Bio | 10/09/2025 | By Mrinmoy Dey
Wheeler Bio Plans for Expansion with Closing of Oversubscribed Series A-1 Financing Round
The USD 35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises.
Wheeler Bio | 25/03/2025 | By Aishwarya | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy